Abstracts tagged "osteoarthritis and proteoglycans"

Abstract Number: 1145 • 2015 ACR/ARHP Annual Meeting
Expression of Xylosyltransferase-1 Is Modulated By Fibronectin Fragment in Human Articular Chondrocytes
Mi Hyun Lee¹, Min Ha Choi¹, Hyun Sook Hwang¹ and Hyun Ah Kim², ¹Division of rheumatology, Hallym University Sacred Heart Hospital, Kyunggi, South Korea, ²Internal Medicine, Hallym Univ Sacred Heart Hosp, Anyang, South Korea
Background/Purpose: Xylosyltransferase-1 (XT-1), encoded by xylt1 gene, is an essential anabolic enzyme to catalyze the initial and rate-determining step in glycosaminoglycan chain synthesis. The effect…
Abstract Number: 75 • 2013 ACR/ARHP Annual Meeting
Decorin-Deficiency Alters Cartilage Stiffness and Attenuates The Development Of Osteoarthritis In Mice
Tobias Gronau¹, Uwe Hansen², Daniela Seidler², Renato Iozzo³, Attila Aszodi⁴, Carina Prein⁵, Hauke Clausen-Schaumann⁵, Karsten Krüger⁶, Frank Mooren⁶, Jessica Bertrand¹, Thomas Pap⁷, Peter Bruckner² and Rita Dreier², ¹Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany, ²Institute for Physiological Chemistry & Pathobiochemistry, University Hospital Münster, Münster, Germany, ³Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, ⁴Experimental Surgery and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany, ⁵Department of Applied Sciences and Mechatronics, Munich University of Applied Sciences, Munich, Germany, ⁶Institute of Sports Medicine, Justus-Liebig University Giessen, Giessen, Germany, ⁷Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany
Background/Purpose: In articular (AC) and growth plate (GP) cartilage, the small leucine-rich proteoglycan decorin is mainly present within the interterritorial regions (ITs) of the extracellular…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].